Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erlotinib with Chemoradiotherapy in Esophageal Squamous Carcinoma
NCT01752205Phase 3Unknown
- Sponsor
- 307 Hospital of the People's Liberation Army
- Start
- Nov 2012
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of erlotinib in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by 307 Hospital of the People's Liberation Army. Status: unknown.
02
Drugs
erlotinib
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT01752205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01752205.